The GALILEO trial has been halted after an early peek at the data showed that rivaroxaban (Xarelto; Bayer/Janssen) was associated with greater risks of all-cause mortality, thromboembolic events, and ...

In the wake of the US Food and Drug Administration (FDA) advisory panel vote to recommend approval of the novel anticoagulant rivaroxaban, physicians are still debating the merits of the ROCKET AF ...

This drug has boxed warnings. These are the most serious warnings from the Food and Drug Administration (FDA). Boxed warnings alert doctors and patients about drug effects that may be dangerous.

Heart transcatheter The FDA has approved the supplemental New Drug Application for Xarelto (rivaroxaban; Janssen) to include updated information for patients with prosthetic heart valves. The Food and ...

Please provide your email address to receive an email when new articles are posted on . Acute left ventricular thrombus occurs in about 3% of all patients with STEMI. Rivaroxaban demonstrated similar ...

We evaluated whether rivaroxaban alone or in combination with aspirin would be more effective than aspirin alone for secondary cardiovascular prevention. In this double-blind trial, we randomly ...